Hematology TimesNew approach to AE reporting needed, group saysJuly 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Hematology TimesHealth Canada expands approval of obinutuzumabJuly 10, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesESMO, ASCO seek improved cancer servicesJuly 8, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology NewsPET-driven chemo strategy helps reduce toxicity in Hodgkin lymphomaJuly 6, 2018Hodgkin LymphomaLymphoma & Plasma Cell Disorders
Hematology TimesTransplant strategy not viable for aggressive B-NHLJuly 6, 2018Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology NewsRapid venetoclax dose escalation aids relapsed CLLJuly 5, 2018Aggressive LymphomasCLLLymphoma & Plasma Cell Disorders
Hematology TimesJAK inhibition linked to B-cell lymphomaJuly 5, 2018CythemiasLymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology NewsDaratumumab plus carfilzomib/dexamethasone effective in lenalidomide-refractory myelomaJuly 2, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesCHMP recommends CAR T for ALL, DLBCLJuly 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesCHMP recommends CAR T for DLBCL, PMBCLJuly 2, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesCHMP backs expanded approval of tocilizumabJuly 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Hematology NewsBortezomib plus vorinostat shows modest response in MCLJune 29, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology TimesDoc reports favorable results from trial on holdJune 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesGroup updates guidelines on CLLJune 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCPI-613 receives orphan designation for BLJune 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
